Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 1622-1637, October 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kensler, C. J.
Right arrow Articles by Wodinsky, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kensler, C. J.
Right arrow Articles by Wodinsky, I.

Toxicology of Anti-leukemic Agents with Special Reference to Phthalanilide Derivatives1

C. J. Kensler, P. E. Palm, H. M. Day, S. P. Battista, W. I. Rogers, D. W. Yesair and I. Wodinsky

Life Sciences Division, Arthur D. Little, Inc., Cambridge, Massachusetts

Some of the toxicologic problems associated with the use of newer agents such as the phthalanilides have been presented. In lieu of the discovery of anti-leukemic agents with much improved therapeutic indices, it is perhaps encouraging in terms of potential combination therapy that limiting toxicologic problems differ. Methods have been developed or adapted which indicate that these toxicologic problems may not be associated with all structurally related compounds with anti-leukemic activity. It is suggested that the area of selective reduction in toxicity by the administration of toxicity-alleviating agents merits increased attention.

1 The experimental studies included in this report have been supported by contract SA-43-ph-3789, Cancer Chemotherapy National Service Center, National Cancer Institute.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.